Dario Tuccinardi on Obesity as Cardiovascular Treatment Target
Dario Tuccinardi, Assistant Professor in Endocrinology at The Bio-Medical University of Rome, shared on LinkedIn:
”Obesity is no longer just a cardiovascular risk factor. It is a cardiovascular treatment target.
Obesity and visceral adiposity actively shape cardiovascular disease, through inflammation, altered myocardial energetics, and diagnostic distortion.
Yet in daily practice, patients with obesity are still affected by clinical bias: symptoms are under-recognized, biomarkers misinterpreted, and treatment decisions delayed or diluted.
Our review argues for a double shift.
First: therapeutic.
Modern anti-obesity pharmacotherapy, especially GLP-1 receptor agonists and dual-incretin agents, extends beyond weight loss.
These drugs improve endothelial function, reduce inflammation, optimize myocardial metabolism, and now demonstrate cardiovascular event reduction even in people with obesity without diabetes.
Second: cultural and clinical.
Cardiologists must be supported in overcoming weight-related bias—moving beyond BMI, recognizing visceral obesity, correctly interpreting biomarkers, and confidently treating obesity as part of cardiovascular care rather than deferring it.
Treating obesity is no longer optional.
It is evidence-based cardiovascular medicine.
Weight loss is not about weight.
It’s about outcomes.”

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America
-
Apr 22, 2026, 07:02Michael Wong: Predicting Blood Clots is a Patient Safety Issue
-
Apr 22, 2026, 07:02Rich Gorman: The Role of Inquiry Findings in Shaping Professional Memory and Learning
-
Apr 22, 2026, 06:01Kathaleen Schnur: Global Perspectives on Psychosocial Support in Hemophilia Care